Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gender Influence on Droperidol Torsadogenic Actions
NCT03944681Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of droperidol in postoperative nausea and vomiting (PONV), sponsored by Medical University of Gdańsk. Primary endpoints: QT and corrected QT interval time and Time interval between T wave peak and T wave end. Started Apr 2019; status: completed.
02
Drugs
droperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03944681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944681.